iSpecimen Inc. Common Stock
ISPCiSpecimen Inc. (ISPC) is a biotechnology company focused on providing a platform that facilitates the procurement of human biospecimens for medical research. Through its digital marketplace, the company connects researchers with a broad network of hospitals, clinics, and tissue banks to expedite the collection and delivery of quality biological samples, supporting advancements in personalized medicine and diagnostics.
Company News
U.S. stock futures declined on New Year's Eve as hopes for a year-end Santa Claus rally fade. Markets remain jittery following President Trump's threats against Federal Reserve Chair Jerome Powell. Investors await the Initial Jobless Claims report before market open. The S&P 500, Dow Jones, and Nasdaq 100 all traded lower in premarket, with sever...
iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for biospecimens, announced a securities purchase agreement with accredited investors for approximately $5.5 million in gross proceeds. The company will issue 6,875 shares of Series C Convertible Preferred Stock at $800 per share, convertible into common stock at 85% of the closing price. Net p...
iSpecimen Inc. closed a private placement of approximately $1.75 million by issuing 1,559,828 shares of common stock at $1.122 per share. The proceeds will be used for marketing services and general corporate purposes.
iSpecimen Inc. closed a $4 million public offering of 5,714,283 shares at $0.70 per share. The company plans to use proceeds for marketing services, milestone payments, and general corporate purposes.
iSpecimen Inc. announced the resignation of a director, the election of two new directors, and the approval of a reverse stock split at its annual shareholder meeting. The company also reported a decrease in revenue for Q1 2024 but highlighted a pipeline of new business opportunities.
